Yujia Dai,Steven D. Fidanze,Lisa Hasvold,James Holms,Dachun Liu,William McClellan,Keith McDaniel,Jasmina Marjanovic,George Sheppard,Le Wang
申请号：
US14392200
公开号：
US10131657B2
申请日:
2014.05.13
申请国别(地区):
US
年份:
2018
代理人:
摘要：
The present invention provides for compounds of formula (I). wherein Rx, Ry, Rx1, L1, G1, A1, A2, A3, and A4 have any of the values defined in the specification, and pharmaceutically acceptable salts thereof, that are useful as agents in the treatment of diseases and conditions, including inflammatory diseases, cancer, and AIDS. Also provided are pharmaceutical compositions comprised of one or more compounds of formula (I).
